Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes
Status:
Completed
Trial end date:
2005-11-22
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe.
A 32-week efficacy and safety comparison of insulin detemir and insulin semilente MC in
children between 6 and 21 years with type 1 diabetes.